Objective
In t-Clinic, a novel medical device will be validated as a new additional tool for early detection and prognosis of a number of pathologies: cancer, sepsis, stroke, diabetes, hypertension, infectious diseases, etc., and for different applications: epidemics, critical care, paediatrics, internal medicine, etc., that are based on subtle changes in the body temperature dynamics, not just in its absolute values (discover hidden information, bring to light undetected trends, find new diagnosis correlations).
Body temperature quantification systems are currently the primary choice for standard clinical practice. However, due to the low sensitivity and specificity of these methods, a limited field of action, and null dynamics perspective, patients are often referred for secondary procedures, such as blood cultures, for more detailed diagnosis information. These referrals pose a global challenge that postpone treatment, increase the patient risks, and entail higher costs to the healthcare system (materials, labour requirements). There is a worldwide need to reduce the temporal and economic diagnosis costs to enable faster treatment of conditions and more affordable and sustainable healthcare systems by introducing preventive screenings and monitorings for earlier interventions.
Innovatec has developed an advanced non-invasive body temperature monitor capable of long-term accurate thermoregulation assessment that can provide a low cost prompt diagnosis tool that will reduce the need for referrals, and will become an effective tool for body temperature dynamics correlation with disorder onset and progression. This is achieved by means of a precise multi-site body temperature monitoring scheme based on a portable wireless device, a set of clinical temperature probes (skin, tympanic, axillary, etc.), and a number of advanced signal entropy estimation algorithms developed by Innovatec's scientists in the last years, which are our most disruptive competitive advantage.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine internal medicine
- medical and health sciences health sciences infectious diseases
- medical and health sciences clinical medicine critical care medicine
- medical and health sciences clinical medicine paediatrics
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3.1.3. - Treating and managing disease
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2014-2015
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
03440 Alcoy
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.